HURRICANE CAPITAL ADVISORS LLC’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-535
Closed -$81.7K – 891
2026
Q1
$81.7K Hold
535
– – 0.03% 460
2025
Q4
$73.8K Sell
535
-985
-65% -$129K 0.02% 488
2025
Q3
$195K Sell
1,520
-280
-16% -$34.2K 0.05% 309
2025
Q2
$218K Hold
1,800
– – 0.05% 236
2025
Q1
$201K Buy
1,800
+535
+42% +$57K 0.07% 199
2024
Q4
$123K Hold
1,265
– – 0.04% 281
2024
Q3
$146K Hold
1,265
– – 0.05% 275
2024
Q2
$135K Hold
1,265
– – 0.05% 257
2024
Q1
$122K Hold
1,265
– – 0.03% 306
2023
Q4
$128K Buy
+1,265
New +$122K 0.05% 233

Other funds holding NVS

HURRICANE CAPITAL ADVISORS LLC's NVS Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC sold out of Novartis (NVS) in Q2 2026, closing a stake of 535 shares — an estimated $81.7K sold.

HURRICANE CAPITAL ADVISORS LLC first reported a position in NVS in Q4 2023 and held it in 10 quarters. The position peaked at $218K in Q2 2025. 1,630 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • HURRICANE CAPITAL ADVISORS LLC sold 535 Novartis shares in Q2 2026, an estimated $81.7K.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Novartis in Q4 2023 and held it in 10 quarters.
  • HURRICANE CAPITAL ADVISORS LLC's Novartis position peaked at $218K in Q2 2025.
  • 1,630 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.